|
C10ORF46 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.408000E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.663500E-03 |
| Normal-vs-Stage2 |
6.859200E-01 |
| Normal-vs-Stage3 |
4.678000E-01 |
| Normal-vs-Stage4 |
7.731400E-01 |
| Stage1-vs-Stage2 |
2.409800E-01 |
| Stage1-vs-Stage3 |
4.050800E-01 |
| Stage1-vs-Stage4 |
3.530600E-01 |
| Stage2-vs-Stage3 |
7.727600E-01 |
| Stage2-vs-Stage4 |
6.684800E-01 |
| Stage3-vs-Stage4 |
4.966000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.272270E-02 |
| Normal-vs-AfricanAmerican |
5.314000E-01 |
| Normal-vs-Asian |
4.867200E-01 |
| Caucasian-vs-AfricanAmerican |
2.306400E-01 |
| Caucasian-vs-Asian |
8.482200E-01 |
| AfricanAmerican-vs-Asian |
5.711000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.424700E-04 |
| Normal-vs-Female |
3.669600E-01 |
| Male-vs-Female |
1.778190E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.718800E-01 |
| Normal-vs-Extreme_Weight |
8.1897000000053E-05 |
| Normal-vs-Obese |
5.438200E-01 |
| Normal-vs-Extreme_Obese |
8.692200E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.223200E-01 |
| Normal_Weight-vs-Obese |
5.210000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.654200E-01 |
| Extreme_Weight-vs-Obese |
9.141700E-03 |
| Extreme_Weight-vs-Extreme_Obese |
9.331800E-01 |
| Obese-vs-Extreme_Obese |
2.378600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.558200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.821800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.760960E-03 |
| Normal-vs-Age(81-100Yrs) |
1.413980E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.420400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.980500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.264200E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.845700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.182000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.690200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.479200E-03 |
| Normal-VS-Type2 PRCC |
2.478100E-03 |
| Normal-VS-KIRP CIMP |
1.037500E-02 |
| Normal-VS-Unclassified PRCC |
7.937600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.977950E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.876800E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.609000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.08959999969949E-07 |
| Type2 PRCC-VS-Unclassified PRCC |
7.052200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.213200E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.5084000000003E-05 |
| Normal-vs-N1 |
3.300200E-01 |
| Normal-vs-N2 |
7.869400E-01 |
| N0-vs-N1 |
7.301400E-03 |
| N0-vs-N2 |
4.813400E-01 |
| N1-vs-N2 |
9.551000E-01 |
|
|
